Real-World Use of Clopidogrel and Ticagrelor in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Patient Characteristics and Long-Term Outcomes

Real-World Use of Clopidogrel and Ticagrelor in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries: Patient Characteristics and Long-Term Outcomes

Background: Current guidelines recommend ticagrelor as the preferred P2Y12 inhibitor on top of aspirin in patients after an acute coronary syndrome. Yet, the efficacy and safety of ticagrelor vs. clopidogrel in patients with myocardial infarction with nonobstructive coronary arteries (MINOCA) remain...

Full description

Bibliographic Details
Main Authors: Side Gao, Haobo Xu, Sizhuang Huang, Jiansong Yuan, Mengyue Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
myocardial infarction with nonobstructive coronary arteries (MINOCA)
dual antiplatelet therapy
ticagrelor
clopidogrel
cardiovascular outcomes
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.807494/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.807494/full

Similar Items